tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market
SRPT
Sarepta Therapeutics
RESEARCH TOOLSreports
Want to see SRPT full AI Analyst Report?

Sarepta Therapeutics (SRPT) Income Statement

4,065 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q4 2025), Sarepta Therapeutics's total revenue was $442.93M, a decrease of -32.73% from the same quarter last year. In Q4, Sarepta Therapeutics's net income was $-282.85M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.20B$ 1.90B$ 1.24B$ 933.01M$ 701.89M
Gross Profit
$ 1.32B$ 1.58B$ 1.09B$ 793.02M$ 604.84M
Operating Expenses
$ 1.97B$ 1.36B$ 1.36B$ 1.33B$ 1.06B
Depreciation and Amortization
$ 44.52M$ 37.72M$ 44.40M$ 41.86M$ 38.02M
EBITDA
$ -647.97M$ 316.89M$ -453.69M$ -594.85M$ -317.41M
Operating Income
$ -657.77M$ 218.08M$ -267.82M$ -536.20M$ -459.71M
Other Income/Expenses
$ -44.45M$ 42.69M$ -252.27M$ -153.76M$ 40.76M
Pretax Income
$ -702.23M$ 260.77M$ -520.10M$ -689.96M$ -418.95M
Net Income
$ -713.41M$ 235.24M$ -535.98M$ -703.49M$ -418.78M
Per Share Metrics
Basic EPS
$ -7.13$ 2.47$ -5.80$ -8.03$ -5.15
Diluted EPS
$ -7.13$ 2.34$ -5.80$ -8.03$ -5.15
Weighted Average Shares Outstanding
 104.79M 95.08M 92.40M 87.56M 81.26M
Weighted Average Shares Outstanding (Diluted)
 104.79M 107.88M 92.40M 87.56M 81.26M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History